Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Clinical trial NCT05854498 · RECRUITING
Trial details
- NCT number
- NCT05854498
- Sponsor
- University of Wisconsin, Madison
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-13
- Primary completion
- 2028-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.